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ABSTRACT: Gynostemma pentaphyllum (the immortal herb) has
been an important component of Chinese Traditional Medicine for
millennia. Recent clinical studies have revealed that the plant
exhibits numerous beneficial biological activities, making it of
interest to the pharmaceutical industry. An extract of the herb
contains over 200 individual secondary metabolites including
flavonol glycosides and dammarane saponins. To focus attention
on the compounds most likely to be responsible for the biological
activities, this study predicts the potential oral bioavailability of
nine dammarane saponins and five flavonol glycosides from G.
pentaphyllum using the Caco-2 cell monolayer permeability model.
Two flavonoids, 8 and 9, and four saponins, 10, 11, 12, and 14,
exhibited high permeability across the monolayers. The results
indicated that a higher degree of glycosylation-facilitated permeability, suggestive of active transport. This study demonstrates the
utility of the Caco-2 permeability assay as a method of identifying possible bioavailable compounds from medicinal herbal extracts.
■ INTRODUCTION
The plant kingdom has been sustenance, medicine, fuel, and
shelter for humankind since our first appearance on this planet.
Our reliance on plants for medicinal purposes is recorded in
our most ancient civilizations.1 The use of plants or plant-
derived substances as drugs is a common feature of all
civilizations, and it continues to be a critical source of
healthcare for much of the world’s population. The past two
decades have seen the herbal medicine industry grow from a
modest to a global industry. The global herbal medicine
market was estimated to be worth US$83 billion in 20082 and,
with a compound annual growth rate of 5.9−7.2%, is expected
to reach US$111 billion in 2023.3 In many parts of Africa and
Asia, particularly in China, over 80% of the population relies
heavily on traditional medicine for primary healthcare.2
Approximately, 20−70% of the population from Australia
and Europe use some form of traditional medicine in personal
healthcare.4 The scientific community has always shown
significant interest in the chemistry and bioactivity of the
compounds isolated from medicinal herbs or extracts. Hence,
bioactivity-guided isolation of natural products is still one of
the major pathways for the discovery of drugs or lead
molecules. While activity-guided isolation of natural products
is an excellent strategy, a somewhat underexploited property of
potentially active compounds is the evaluation of the oral
bioavailability of compounds in a complex herbal extract. In
this study, we address this issue by investigating the potential
bioavailability of the flavonoids and saponins isolated from a
Chinese medicinal herb, Gynostemma pentaphyllum (Thunb.)
Makino, using the Caco-2 cell monolayer permeability model
to provide some direction as to which of the many compounds
present in this complex herb might be responsible for its
undoubted pharmacological activity.
G. pentaphyllum, a member of the Cucurbitaceae family, is a
perennial herb, native to China, Korea, Japan, and Vietnam,
and its distribution extends to Bangladesh, Sri Lanka,
Myanmar, Thailand, Laos, Malaysia, and Indonesia.12 G.
pentaphyllum, also known as “jiaogulan,” “the immortal herb”,
or “xiancao”, has been used in folk medicine for centuries and
is believed to exhibit numerous medicinal properties.13 Reports
suggest that G. pentaphyllum possesses activity against asthma
and inflammation,13 obesity,14,15 and hyperlipidemia16 and has
shown antitumor,16,17 antipeptic ulcer,18 adaptogenic,19 and
cardiovascular and cerebrovascular activities.20 Most of these
bioactivities exhibited by G. pentaphyllum are thought to be
due to the presence of two groups of bioactive compounds,
saponins and flavonoids. Reports suggest that approximately
165 saponins are present in G. pentaphyllum.18,21 The major
saponins present in G. pentaphyllum belong to the dammarane
class of saponins (known as gypenosides, if isolated from G.
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pentaphyllum). Dammarane saponins are characterized by a
dammarane aglycone with an acyclic side chain (Figure 1).
Dammarane aglycones are tetracyclic triterpenoid sapogenins
in which C-1, C-2, C-3, C-12, and C-20 positions are either
hydroxylated or glycosylated and the C-17 position can possess
a variety of modified side chains. A variety of flavonoids have
also been isolated from G. pentaphyllum with the free aglycone
forms (quercetin, kaempferol, and isorhamnetin) being
reported;21,22 however, the most prominent flavonoids present
in G. pentaphyllum are found as quercetin and kaempferol
glycosides (Figure 2).22
A large number of studies have already established the
diverse pharmacological benefits of organic or aqueous crude
extracts of G. pentaphyllum or of a saponin-rich extract
preparation. The extracts have shown significant activities
against coronary spasm and arrhythmia,23 diabetes,24 and the
development of cancerous cells.25−27 The saponin-rich extracts
also exhibited excellent activities against platelet aggregation28
and inhibited the growth of Streptococcus mutans29 and
Helicobacter pylori.30 A recent study by Nguyen et al. reported
that two saponins, damulins A and B (15 and 16; Figure 1),
isolated from G. pentaphyllum are potential activators of AMP-
activated protein kinase (AMPK).15 AMPK is responsible for
the regulation of blood sugar levels and lipid metabolism,
consequently resulting in weight loss. Gauhar et al. performed
a follow-up in vivo study that reported the antiobesity effect of
G. pentaphyllum extract in obese mice.31 The antiobesity effect
of G. pentaphullum was established by a clinical trial in humans
by Park et al.14 The effects on body weight, fat loss, and
metabolic markers of Korean participants were investigated in
a 12-week, randomized, double-blind, placebo-controlled
clinical trial, which suggested that G. pentaphullum supple-
mentation may be effective for treating obese individuals.
This highly potent, safe, and effective plant extract could be
the first choice for treating or preventing many health
disorders; however, the complex chemical profile of G.
pentaphyllum makes it difficult to identify the individual
bioactive compounds from a complex mixture (Figure 3) of
hundreds of natural products. This necessitates a systematic
approach that can differentiate the complex mixture and allow
researchers to confidently focus their attention on a smaller
subset of compounds to evaluate their potential bioactivities.
Our strategy for this relies on the knowledge that the
traditional use of this herb is as an orally ingested extract
and thus the compounds most likely to be responsible for the
bioactivity must be orally bioavailable. To rapidly and
efficiently evaluate the relative potential oral bioavailability of
a significant number of compounds, the Caco-2 cell monolayer
permeability model is an ideal in vitro approach.
The Caco-2 cell monolayer permeability model has emerged
as the leading in vitro tool for the assessment of potential
bioavailability of drugs in the human body. Established by
Fogh in 1974,5 this model has been extensively used in
predicting in vivo oral absorption of natural and synthetic
products in humans.6−8 Caco-2 cells provide an excellent
Figure 1. Structures of saponins isolated from G. pentaphyllum.
Figure 2. Structures of flavonoids isolated from G. pentaphyllum. Figure 3. Liquid chromatography−mass spectrometry (LC−MS)
trace of the crude methanol extract of G. pentaphyllum leaves (a)
before hydrolysis and (b) after hydrolysis with HCl/methanol.
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physical and biochemical mimic of the human intestinal
epithelial membrane.5 When the cells are cultured following
specific protocols9 and they reach expected differentiation and
confluency, they express all the major transport proteins
present in the human small intestine such as active transporters
including sugar transporters, e.g., SGLT1, GLUT2, and
GLUT5,10 thus allowing passive diffusion as well as active
and passive transport to be investigated.11 They also express
efflux proteins such as P-glycoprotein (P-gp), breast cancer
resistance protein (BCRP), and multidrug resistance-associ-
ated protein 2 (MRP-2).11 This model enables both apical to
basolateral and basolateral to apical transport to be studied,
with the apical compartment mimicking the intestinal lumen
and the basal compartment mimicking the bloodstream. This
model assesses the apparent permeability coefficient (Papp)
values of molecules, which is a measure of the rate at which a
compound can cross an area of the cell monolayer. The Papp of
a number of passively diffused drugs was plotted against the
absorbed fraction of these drugs after oral administration in
humans and a clear correlation emerged, suggesting that this
assay can be used to predict the absorption in humans,
provided that factors such as the drug solubility and
metabolism can be accounted for with the help of other
assays.7 These advantages made this model our first choice to
investigate the potential bioavailability of compounds isolated
from G. pentaphyllum.
Even though the chemistry of G. pentaphyllum has been
extensively investigated, surprisingly, there is an extremely low
number of reports on the bioavailability of the flavonoids
present in the plant. Here, for the first time, we report the
Caco-2 cell monolayer permeability profiles of five flavonoids
(2, 3, 4, 5, and 9; Figure 2) along with some previously
reported flavonoids for comparison: kaempferol (1), quercetin
(6), isoquercitrin (7), and rutin (8). The Caco-2 cell
monolayer permeability of dammarane saponins has never
previously been investigated and thus we report the relative in
vitro monolayer permeability profiles of nine damarane
saponins (10−18; Figure 1) from G. pentaphyllum.
■ RESULTS AND DISCUSSION
The Caco-2 monolayer permeability assay was conducted
following standard protocols.9,32 The Caco-2 cells were seeded
onto transwells and maintained for 21 days when they were
fully confluent and functional monolayers. The integrity of the
Caco-2 monolayers was assessed by measuring the trans-
epithelial electrical resistance (TEER) and the TEER values for
the transwells fell within the acceptable range (400−600 Ω·
cm2) for fully confluent monolayers with well-established tight
junctions between the cells.33 The permeability assay was
conducted by placing 100 μL of a 1 mg/mL solution
(dissolved in Hank’s buffered salt solution (HBSS)−4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buf-
fer) of the compound to be assayed into the apical chamber
and 400 μL of HBSS−HEPES buffer into the basolateral
chamber. Samples from the basal side were taken and replaced
with the equivalent amount of buffer every 30 min for 150 min.
Propranolol and fluorescein were used as the positive and
negative control compounds for the assays, respectively.
Propranolol, a completely orally bioavailable compound with
>90% absorption in the human gastrointestinal tract, exhibits a
very high apparent permeability (Papp) value in Caco-2 cell
permeability assays (Papp > 20 × 10
−6 cm/s), whereas
fluorescein is a poorly orally bioavailable compound that
exhibits extremely low Papp values (Papp < 1 × 10
−6 cm/s)
across Caco-2 cell monolayers. Hence, propranolol and
fluorescein represent the upper and lower bounds for the
permeability assays performed on the flavonoids and saponins
reported in this paper. These control compounds exhibited
permeability values within the expected ranges, propranolol
((56.0 ± 8.88) × 10−6 cm/s) and fluorescein ((0.1 ± 0.002) ×
10−6 cm/s),32 providing further evidence of good monolayer
integrity (Table 1). To evaluate the physical integrity of the
monolayers after exposure to the compounds for 150 min, the
permeability of fluorescein across the washed monolayers was
determined after the assay was complete (postrun fluorescein
assay). The postrun fluorescein control assay also gave
consistently low Papp values (Table 1) for cells exposed to
the compounds, indicating that none of the monolayers had
been damaged during the assay and that the compounds were
not toxic to the cells.
The flavonoids selected for the permeability assay showed
apparent permeability coefficient values in the range of 1.17
(±0.128) × 10−6 to 36.6 (±3.2) × 10−6 cm/s (Table 1 and
Figure 4). A comparison of the Papp values of propranolol and
fluorescein showed that the majority of the flavonoids
exhibited moderate to high monolayer permeability.
Three quercetin glycosides with varying degrees of
glycosylation were examined in this assay along with their
aglycone, quercetin (6). They showed Papp values in the range
of 1.70 (±0.11) × 10−6 to 36.6 (±3.2) × 10−6 cm/s. All of the
quercetin glycosides showed higher Papp values than that of
quercetin (1.70 (±0.11) × 10−6 cm/s). Compound 7, a
Table 1. Apparent Permeability Coefficient (Papp) Values of Flavonoids from G. pentaphyllum with Postrun Fluorescein Assay
Values
permeability assay postrun fluorescein assay
compounds Papp (cm/s) (±SD) × 10
−6 cm/s (0−150 min)a,b *Papp (cm/s) (±SD) × 10−6 cm/s (0−60 min)a,b
propranolol 56.0 (±8.88)
fluorescein 0.1 (±0.002)
1 1.17 (±0.13) 0.38 (±0.045)
2 1.83 (±0.34) 0.48 (±0.098)
3 2.09 (±0.28) 0.24 (±0.059)
mixture of 4 and 5 6.60 (±0.75) 0.23 (±0.058)
6 1.70 (±0.11) 0.23 (±0.06)
7 2.05 (±0.22) 0.24 (±0.059)
8 24.5 (±1.21) 0.48 (±0.098)
9 36.6 (±3.2) 0.38 (±0.041)
aAverage values were taken from two different experiments. bNumber of replicates, n = 3−4.
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glycoside with one sugar unit exhibiting moderate permeability
(2.05 (±0.22) × 10−6 cm/s) while compound 8 with two
sugars and compound 9 with three sugars exhibited Papp values
of 24.5 (±1.21) × 10−6 and 36.6 (±3.2) × 10−6 cm/s,
respectively. These values corresponded to a 12-fold and 18-
fold increase in permeability compared to that of 7. These
results indicated that the permeability of the quercetin
glycosides increased significantly as the degree of glycosylation
increased, suggesting that glycosylation facilitates the perme-
ability across Caco-2 monolayers. A similar trend was observed
in the case of kaempferol glycosides. The Papp value for
kaempferol (1) was 1.17 (±0.13) × 10−6 cm/s, whereas
compounds 2 and 3, both having two sugar units, exhibited
slightly higher Papp values of 1.83 (±0.34) × 10
−6 and 2.09
(±0.28) × 10−6 cm/s, respectively. The mixture of two
isorhamnetin glycosides (4 and 5) also showed moderate
permeability across Caco-2 monolayers with a Papp value of
6.60 (±0.75) × 10−6 cm/s, indicating potential human oral
bioavailability.
The Papp value of quercetin was higher than that of
kaempferol. The only difference between these two com-
pounds is the presence of a hydroxyl group at position C-3′
(R2, Figure 2) in quercetin. This hydroxyl group is replaced by
a methoxy group in isorhamnetin derivatives. When the Papp
values for all of the flavonol glycosides with two sugars were
compared, it was found that quercetin glycoside 8 showed
higher monolayer permeability than the isorhamnetin (4 and
5) and kaempferol glycosides (2 and 3). The lowest Papp values
among these glycosides with two sugars were attributed to the
kaempferol glycosides 2 and 3, suggesting that the hydroxyl
functionality at position 3′ may affect intestinal permeability,
possibly by facilitating transporter recognition and binding.
A recent study correlated Caco-2 cell monolayer perme-
ability with the likely oral bioavailability in humans. They
characterized Papp values of <(1−2) × 10−6 cm/s as low
permeability corresponding to 0−20% human fraction
absorbed (Fa), Papp values of 2−10 × 10−6 cm/s as moderate
permeability corresponding to 20−80% Fa and Papp > 10 ×
10−6 cm/s as high permeability indicating 80−100% Fa.34 With
these values as a guide, compounds 2, 3, 4, 5, and 7 with the
aglycones kaempferol and quercetin can be said to show low to
moderate membrane permeability across Caco-2 monolayers,
whereas compounds 8 and 9 exhibited high Caco-2 cell
permeability, making them strong candidates for human oral
bioavailability. Previous studies on the intestinal membrane
permeability of quercetin and kaempferol confirmed that both
aglycones cross Caco-2 monolayers via passive diffusion.35,36 It
has also been reported that glycosylation generally leads to a
decrease in Caco-2 monolayer permeability unless significant
active transport occurs.37−39 Caco-2 cells are known to express
active transporters, including sugar transporters, such as
SGLT1, GLUT2, and GLUT5.10 A study by Liu et al. also
reported that a sugar transporter, SGLT1, is responsible for the
transport of glycosides in Caco-2 cells.40 Analyzing our
permeability assay data with the literature reports in mind, it
can be interpreted that the glycosylated flavonoids assessed
here may be actively transported, possibly by sugar transporters
across Caco-2 monolayers.
The nine dammarane saponins selected for an assessment in
the Caco-2 monolayer permeability assay in this study
displayed Papp values in the range of 1.33 (±0.073) × 10
−6
to 35.3 (±5.8) × 10−6 cm/s (Table 2 and Figure 5).
Gypenoside LVI (11), a saponin with four sugar units, two at
C-3 and two at C-20 (Figure 1), showed the highest Papp value
of 35.3 (±5.8) × 10−6 cm/s, indicative of high to complete
human oral bioavailability. The lowest Papp value of 1.33
(±0.073) × 10−6 cm/s was attributed to damulin A (15), an
E1 elimination product of 11, and a saponin with two glucose
units at C-3 (Figure 1). Gypenoside XLVI (10), bearing three
glucose units, two at C-3 and one at C-20, exhibited a Papp
value of 15.7 (±1.16) × 10−6 cm/s, a twofold decrease in
Figure 4. Caco-2 monolayer permeability assay on standards and
flavonoids.
Table 2. Apparent Permeability Coefficient (Papp) Values of Saponins from G. pentaphyllum with Postrun Fluorescein Assay
Values
permeability assay postrun fluorescein assay
compounds *Papp (cm/s) (±SD) × 10−6 cm/s (0−150 min)a,b *Papp (cm/s) (±SD) × 10−6 cm/s (0−60 min)a,b
propranolol 56.0 (±8.88)
fluorescein 0.1 (±0.002)
10 15.7 (±1.16) 0.59 (±0.073)
11 35.3 (±5.8) 0.28 (±0.047)
12 10.7 (±2.09) 0.52 (±0.069)
13 1.39 (±0.088) 0.59 (±0.073)
14 13.6 (±1.61) 0.28 (±0.046)
15 1.33 (±0.073) 0.52 (±0.013)
16 3.56 (±0.530) 0.21 (±0.037)
17 5.8 (±0.770) 0.52 (±0.012)
18 6.2 (±0.248) 0.51 (±0.075)
aAverage values were taken from two different experiments. bNumber of replicates, n = 3−4.
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permeability compared to the four sugar bearing 11. As seen
previously for the flavonoids, a higher degree of glycosylation
also favors monolayer permeability of the saponins. Gypeno-
sides LVI (11) and XLVI (10) are both glycosylated at two
sites on the molecule and bear a total of four and three sugar
units, respectively, and exhibit higher Papp values than all
saponins investigated here.
Gypenoside L (12), with the C-3 disaccharide, showed high
permeability with a Papp value of 10.7 (±2.09) × 10
−6 cm/s.
Interestingly, gypenoside LI (13), the 20R-epimer of 12,
exhibited a 10-fold decrease in permeability (1.39 (±0.088) ×
10−6 cm/s). This may suggest that the stereochemistry at C-20
(Figure 1) can be a significant factor for determining the
monolayer permeability of the saponins. Yixinoside B (14)
exhibits the same C-20 stereochemistry as 12 and bears two
glucose units attached through the hydroxy group at C-3 but is
hydroxylated at position C-1 rather than at C-2 as seen in 12
and 13 (Figure 1). This structural isomer of 12 exhibited a
slightly higher Papp value (13.6 (±1.61) × 10
−6 cm/s) than 12,
suggesting that a saponin possessing a hydroxyl group at C-1
and S-configuration at C-20 is more permeable across Caco-2
monolayers than its structural or configurational isomers.
The E1 products of gypenosides LVI and XLVI, the
damulins A (15) and B (16) (C-2-OH) and the C-3-OH
isomers, damulins E (17) and F (18), exhibited low to
moderate monolayer permeability with Papp values ranging
from 1.33 (±0.073) to 6.2 (±0.248) × 10−6 cm/s. Damulins A
and B (15 and 16) differ only in the position of the double
bond at C-20 of the side chain, with 15 being the Δ20,22 isomer
and 16 the less stable terminal double-bond isomer (Δ20,21).
Damulins E and F (17 and 18) share the same structural
relationship (Figure 1). A comparison of the Caco-2 cell
monolayer permeability of these compounds reveals a slight
increase in apparent permeability in those compounds with the
terminal double bound 16 and 18. The previous comparison of
the permeability of gypenoside L (12) and yixinoside B (14)
suggested that hydroxylation at C-1 favored permeability over
hydroxylation at C-2 and a similar trend was observed for the
damulins. Damulins E and F (17 and 18), both having
hydroxyl group at C-1, exhibited higher Papp values than that of
the C2-OH isomers, damulins A and B (15 and 16). This
confirms that the monolayer permeability is facilitated by the
presence of a hydroxyl group at C-1 more than at C-2. The
analysis of the Papp values confirmed that compounds 15−18
showed low to moderate permeability across Caco-2
monolayers, whereas the compounds 10, 11, 12, and 14
exhibited high Caco-2 cell monolayer permeability, making
them strong candidates with the potential for high oral
absorption in vivo.
A literature survey confirmed the lack of any report on the
permeability of dammarane saponins. However, reports suggest
that the other class of saponins, the steroidal saponins, can pass
through Caco-2 monolayers. These saponins are actively
transported by suitable transport proteins, such as sugar
transporters, or can be effluxed across the monolayers by efflux
pumps such as P-gp and MRP-2.10,41−45 We know that Caco-2
cells express active transporters including sugar transporters
such as SGLT1 (responsible for the transport of glycosides),40
GLUT2 and GLUT5.10 Analysis of our permeability assay data
in light of these literature reports suggests that the glycosylated
saponins assessed here may be actively transported by sugar
transporters across Caco-2 monolayers. The low permeability
of saponins 13 and 15 may be attributed to the fact that these
saponins are effluxed across Caco-2 monolayers by suitable
efflux pumps such as P-gp and MRP-2. An inhibitory transport
study can be used in the future to determine the specific
transporters or efflux proteins that are involved.
■ CONCLUSIONS
G. pentaphyllum is an important medicinal herb with promising
and clinically important biological activities. It also contains a
plethora of structurally diverse natural products, any or all of
which may be responsible for the activities observed for the
extracts. Our study identifies the compounds most likely to be
orally available from the complex mixture that is ingested as
“the immortal tea”. The Caco-2 cell monolayer permeability
assay on the flavonoids and saponins from G. pentaphyllum
resulted in the identification of strong candidates for potential
human oral bioavailability. The study indicated that kaempfer-
ol glycosides 2−5 exhibited moderate to high permeability
across Caco-2 cell monolayers. A notable observation was that
the Papp value was not significantly affected by the presence of
different sugar units as galactose-containing compounds 2 and
4 showed similar Papp values to the glucose-containing
compounds 3 and 5, respectively. The quercetin glycoside 7
also exhibited moderate permeability across Caco-2 cell
Figure 5. Caco-2 monolayer permeability assay on standards and
saponins.
Figure 6. Summary of the structural features of G. pentaphylum flavonoids and saponins that enhance permeability across Caco-2 cell monolayers.
Key structural features highlighted in red.
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monolayers, whereas other quercetin glycosides 8 and 9 with a
higher degree of glycosylation exhibited high Caco-2 cell
permeability. Quercetin glycosides exhibited higher perme-
ability across Caco-2 monolayers than kaempferol and
isorhamnetin glycosides. It was also observed that the
permeability of the glycosides was dependent on the number
of sugar units attached to the aglycone and the number of
glycosylation sites with a higher degree of glycosylation
facilitating the permeability across Caco-2 cell monolayers.
Figure 6 provides a summary of the key structural features that
our data suggest are critical for enhanced permeability across
Caco-2 cell monolayers and therefore for potential bioavail-
ability.
A similar trend was observed for the highly glycosylated
dammarane saponins, 10 and 11, where the permeability
across Caco-2 cell monolayers was favored by a higher degree
of glycosylation. Analysis of the structure−permeability
correlations revealed that saponins with a hydroxyl group at
C-1 and S-configuration at C-20 were more permeable across
Caco-2 cell monolayers than the structural or configurational
isomers. It was also observed that the compounds that result
from the elimination of the C-20-OH group, compounds 15−
18, showed low to moderate permeability across Caco-2 cell
monolayers, whereas the precursor compounds, 10, 11, 12, and
14, exhibited high Caco-2 cell monolayer permeability, making
them strong candidates for possible complete human oral
bioavailability. Figure 6 depicts these permeability-enhancing
structural features highlighted in red. Based on the literature
reports on the bioavailability of other classes of saponins and
comparison with our results, we propose that the flavonoids
and saponins with moderate to high permeability across Caco-
2 cell monolayers are transported via active transport, possibly
by sugar transporters. This study does not implicate the
involvement of specific uptake transporters or efflux pumps. In
the future, transport studies can be utilized to determine the
specific transporters involved in the active transport of these
compounds. This was the first bioavailability study of
dammarane saponins and also of a number of flavonoids
from G. pentaphyllum, and the results have definite significance
in allowing future bioavailability assays to identify potential
drugs for oral administration or structures for lead
optimization.
■ EXPERIMENTAL SECTION
General Procedures. Human colorectal adenocarcinoma
(Caco-2) cells were purchased from American Type Cell
Culture Collection (ATCC, Rockville, MD). The cells were
cultured and maintained using standard protocols.46 Dulbec-
co’s modified Eagle’s Medium (DMEM), Hanks’ Balanced
Salts Solution (HBSS), 4-(2-hydroxyethyl)-1-piperazine-
ethane-sulfonic acid (HEPES), minimum essential medium
(MEM) nonessential amino acids (NEAAs), trypsin-0.25%
ethylenediaminetetraacetic acid (EDTA) solution, phosphate-
buffered saline (PBS) solution, and penicillin−streptomycin
antibiotic solution were purchased from Gibco Laboratories
(Life Technologies Inc., Grand Island, NY). Fetal bovine
serum (FBS) was bought from Sigma Aldrich Pty Ltd (Castle
Hill, NSW, Australia). Transwell plates (24 wells, 6.5 mm
polycarbonate inserts, 0.4 μm pore) were obtained from
Corning Costar (Cambridge, MA) and LCMS grade
acetonitrile solvent was from Fisher Scientific (Hampton,
NH).
Cell Culture. Flask media was prepared with DMEM
supplemented with 1% NEAA and 10% prefiltered (0.22 μm)
FBS. Plate media was made up of flask media and additionally
supplemented with 1% penicillin (5000 units/mL)-streptomy-
cin (5000 μg/mL) antibiotic. Freezing media was made up of
flask media and additionally supplemented with 10% dimethyl
sulfoxide (DMSO).
Caco-2 cells (passage 34) were removed from the −80 °C
freezer, thawed in a water bath at 37 °C for 1−2 min,
resuspended in flask media (5 mL), and centrifuged (1000
rpm, 5 min). After discarding the supernatant, the cells were
resuspended in flask media (1−2 mL). Gentle mixing using a 5
mL serological pipette gave a homogeneous mixture. The cells
were then seeded into 75 cm2 flasks (Thermo Scientific) by
transferring cell suspension (0.5−1 mL) and flask media (10
mL) to each flask. The flasks were stored in an incubator (37
°C, 5% CO2, 95% relative humidity). The media in the flask
was changed every two days until the cells reached 80−85%
confluency at which time the cells were passaged or plated.
To passage the cells, flask media was removed and the cells
were washed with PBS (2 × 1−2 mL). Trypsin−0.25% EDTA
(3 mL) was added and the flasks were incubated for 5 min,
agitated 2−3 times to encourage cell detachment. Following
successful detachment, flask media (3 mL per 1 mL trypsin)
were added and the cells were centrifuged (1000 rpm, 5 min).
The supernatant was discarded and the cells were resuspended
homogeneously in the flask media (1−2 mL). The cells were
seeded into fresh flasks and maintained as previously described.
To seed the cells into transwell plates, the plates were
preincubated with plate media (100 μL apical and 600 μL
basal) for at least 30 min. The protocol for passaging cells was
followed until the removal of supernatant from centrifuged
cells. Cells were then resuspended in plate media (4−5 mL)
and counted on a hemocytometer (BlauBrand), and the cell
resuspension dilution was adjusted to a density of 1 × 105
cells/mL. The media were then removed from the plates, the
basal side was refreshed (600 μL), and cells (passage 38) were
seeded onto the apical side (100 μL). Plates were cultured in
an incubator (37 °C, 5% CO2, 95% relative humidity) for 21
days. Plate media were refreshed every 48 h until day 8. From
day 8 and later, apical plate media were refreshed every 24 h,
while the 48 h feeding pattern was maintained for the basal
side. On day 21, all plate media were refreshed and TEER
values were measured (Millicell Electrical Resistance System
(ERS-2) volt ohmmeter). Values in the acceptable range of
400−600 Ω·cm2 were recorded. Wells were arranged in
descending order of TEER value to minimize variation
between compound replicates.
Extraction, Isolation, and Characterization of Flavo-
noids and Saponins. The flavonoids selected for the assay
were extracted, isolated, and purified from a methanol extract
of G. pentaphyllum leaves (flavonoids) and the saponins from
the ethanol extract of ActivAMP powder, a commercial
saponin-rich preparation of G. pentaphyllum leaves. The plant
material was originally sourced from Fujian, China, by Huisong
Pharmaceuticals, China. Dried leaves of G. pentaphyllum were
purchased from Huisong Pharmaceuticals, China (Lot No.
GP112-160602). The extract identification, specification, and
certificate of analysis were prepared by Hongbin Chen and
authorized by Liuzi Huang from Huisong Pharmaceuticals.
ActivAMP powder was purchased from Gencor Pacific Limited
(Batch No. BGP30151001). The certificate of analysis was
prepared by Gencor Pacific Limited.
ACS Omega http://pubs.acs.org/journal/acsodf Article
https://dx.doi.org/10.1021/acsomega.0c02180
ACS Omega 2020, 5, 21561−21569
21566
Dried leaves of G. pentaphyllum (10 g) were extracted with
50% aqueous methanol (100 mL), followed by sonication (3 ×
10 min). After filtration and removal of the solvent, the crude
extract (1 g) was partially purified by solid-phase extraction
(Phenomenex Strata C-18E cartridge, 55 μm, 70 Å), eluted
with water, followed by 10, 20, 30, and 40% aqueous methanol
and 100% methanol taking three aliquots (3 × 100 mL) of
each solvent composition. The 30% aqueous methanol fraction
(103 mg) was dried, dissolved in 20% aqueous acetonitrile (6
mL), filtered (0.22 μm Millex syringe filter), and further
purified by column chromatography using preparative
reversed-phase high-pressure liquid chromatography
(RPHPLC) (gradient elution, 2−20% aqueous acetonitrile
over 25 min, 25.0 mL/min) to give compounds 1−9 that were
identified by literature values from nuclear magnetic resonance
and mass spectrometry analyses.47
ActivAMP powder form of G. pentaphyllum (10 g) was
extracted with 60% aqueous ethanol (100 mL), followed by
sonication (3 × 10 min). After filtration and removal of the
solvent, the crude extract (1 g) was partially purified by solid-
phase extraction (Phenomenex Strata C-18E cartridge, 55 μm,
70 Å), eluted with water, followed by 60, 70, 80, and 90%
aqueous methanol and 100% aqueous methanol taking three
aliquots (3 × 100 mL) of each solvent composition. The 70%
aqueous methanol fraction (116.2 mg) was dried, dissolved in
50% aqueous acetonitrile (6 mL), filtered (0.22 μm Millex
syringe filter), and further purified by column chromatography
using semipreparative RPHPLC (40% aqueous acetonitrile
isocratic over 30 min, 2.0 mL/min) to give compounds 10−18
that were identified by literature values from nuclear magnetic
resonance and mass spectrometry analyses.47
Preparation of Assay Samples, Standard Solutions,
and Calibration Curves. Compound solutions (1 mg/mL)
and propranolol (0.1 mM, 0.026 mg/mL) and fluorescein (0.4
mg/mL) standards were made up in warmed HBSS (pH 7.4)
containing 25 mM HEPES and sonicated to maximize
dissolution.
To produce the calibration curves, stock solutions of all of
the compounds (1000 ppm) were made in the HBSS/HEPES
buffer. The stock solutions were serially diluted to achieve
concentrations of 500, 250, 125, 100, 50, 25, 12.5, 10, 5, 2.5,
and 1 ppm. The solutions were analyzed by LCMS, and the
calibration curves were assembled using Microsoft Excel 2016.
Permeability Assay. The apical and basolateral compart-
ments of the wells were prepared by removing all media,
washing twice with PBS and twice with warmed HBSS/HEPES
buffer, gently aspirating to remove all possible liquid, loading
fresh buffer, and incubating the plates for 30 min. The buffer
was removed and the wells gently aspirated to remove all
possible liquid. Fresh buffer was loaded into the basal sides
(600 μL) and the compounds and the standards were loaded
into quadruplicate apical wells (100 μL). Then, the plates were
placed into a shaking incubator (37 °C, 55 rpm). The samples
were taken from the basal side (200 μL) and replaced with
buffer every 30 min for 150 min. At 150 min, the apical side
was also collected. The samples were stored at −80 °C for
further LCMS analysis.
Fluorescein Postrun Control Assay. Transwells were
prepared by removing all media and washing twice with PBS
buffer and twice with prewarmed HBSS/HEPES buffer.
Fluorescein (100 μL) was loaded into each apical well used
for compounds. The plates were placed in the shaking
incubator (37 °C, 55 rpm). The samples were taken from
the basal side (200 μL) and replaced with buffer every 20 min
for 60 min. The samples were stored at −80 °C for further
analysis. The fluorescein postrun control assay was not
conducted on the propranolol or fluorescein wells.
Sample Analysis. Fluorescein standard solutions for
calibration curves, fluorescein standard solutions for perme-
ability assay, and postrun samples were analyzed in 96-well
plates using ultraviolet−visible (UV−vis) spectrophotometry
(490 nm, BioRad Microplate Reader). The compounds and
propranolol standards were analyzed on a Shimadzu LCMS-
2020 system using an analytical column (Shim-pack XR-
ODSIII 2.0 mm i.d × 150 mm, flow rate of 0.25 mL/min,
column oven at 40 °C). Acetonitrile with 0.1% formic acid and
ultrapure water (Milli-Q) with 0.1% formic acid were used as
mobile phases. A gradient elution system was used. The initial
solvent concentration was kept at 5% aq. acetonitrile for 5 min,
then increased up to 80% aq. acetonitrile over 2 min, and held
for 8 min.
Compound peak areas were individually integrated from MS
data on selected ion monitoring (SIM) mode and processed,











where VR is the volume in the receiver chamber, A is the
surface area of the monolayer, C0 is the initial concentration in
the donor chamber (apical) at 0 min, and dC/dT is the steady-
state linear rate of change of concentration in the receiver
chamber (basal) (μg/sec). The rate of drug transport was
calculated by linear regression analysis using Microsoft Excel
2016 software (Microsoft Corporation, Redmond, WA). All
data were presented as mean ± SD in cm/s × 10−6.
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